Classification and regression trees to identify COPD subgroups in clinical trial populations: insights from the IMPACT trial. | ClinicLens
Heterogeneity in chronic obstructive pulmonary disease (COPD) challenges the identification of optimal treatment populations. Subgroups derived from real-life cohorts using classification and regression trees (CARTs) have shown prognostic value for mortality, but their applicabil
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.